About
Develops novel antibiotics to overcome drug-resistant bacteria using a proprietary machine-learning platform to discover and design new antimicrobial compounds.
Explore Oppilotech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.